US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
All News
Headline News
Barchart.com
Benzinga
BreakingCrypto
Chartmill
Finterra
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
MarketMinute
PredictStreet
StockStory
Stocktwits
Talk Markets
TokenRing AI
Press Releases
24-7 Press Release
AB Newswire
ACCESS Newswire
ACN Newswire
Actusnews Wire
Authority Press Wire
B2i Digital
Brandpoint
BusinesNews Wire
Business Wire
CannabisNewsWire
CryptoCurrencyWire
FinancialNewsMedia
First Publisher
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
NewMediaWire
Newsfile
NewsUSA
Newswire.com
PR Underground
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
PulseBulletin.com
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
StatePoint
TheNewswire
Visibility
Worldnewswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Bargain Hunting: Why Off-Price Retail Is Winning
↗
Today 7:55 EST
Via
MarketBeat
Tickers
BURL
ROST
TJX
Hikma Pharmaceuticals Confident on 2026 Targets Despite Flat Injectables Sales
↗
Today 7:12 EST
Via
MarketBeat
Topics
Supply Chain
Exposures
Supply Chain
Guardant Health Sees Shield Coverage Boost in 2027, Holds Cash Flow Break-Even Target
↗
Today 6:12 EST
Via
MarketBeat
Topics
Artificial Intelligence
Tickers
GH
Exposures
Artificial Intelligence
F5 Sees AI and Software Renewals Driving Growth After $100 Million in AI Bookings
↗
Today 5:12 EST
Via
MarketBeat
Topics
Artificial Intelligence
Tickers
FFIV
NVDA
Exposures
Artificial Intelligence
Magnite Targets Global Markets and Live Sports After 39% CTV Growth
↗
Today 4:12 EST
Via
MarketBeat
Tickers
MGNI
ROKU
Citizens Financial Group Targets $450 Million Tech Boost as Private Banking Grows
↗
Today 3:12 EST
Via
MarketBeat
Tickers
CFG
JPM
Nektar Therapeutics Maps Key REZPEG Data Milestones for 2027 and 2028
↗
Today 1:12 EST
Via
MarketBeat
Tickers
NKTR
UBS
Ardelyx Targets 2027 Profitability as IBSRELA Faces Insurance Hurdles
↗
Today 0:12 EST
Via
MarketBeat
Tickers
ARDX
Quest Diagnostics Sees Hospital Deal Growth as 2027 Medicare Cuts Loom
↗
November 21, 2026
Via
MarketBeat
Tickers
DGX
Lakefront Biotherapeutics Eyes 2027 Trials for Autoimmune Drug, Backed by €2.2 Billion in Cash
↗
November 21, 2026
Via
MarketBeat
Tickers
GILD
LKFT
Nasdaq Targets 2027 Equity Token Launch as AI and FinTech Growth Accelerate
↗
November 21, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Fraud
Tickers
JPM
NDAQ
Exposures
Artificial Intelligence
Legal
Paychex Weighs Florida Insurance Shift as Outsourced HR Business Grows
↗
November 21, 2026
Via
MarketBeat
Topics
Economy
Tickers
PAYX
Exposures
Economy
RingCentral Bets on AI Growth as Paid AI ARR Doubles and Margins Hold Firm
↗
November 21, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Tickers
RNG
RY
TSX:RY
Exposures
Artificial Intelligence
Nektar Therapeutics Targets December for Phase 3 Alopecia Trial as REZPEG Advances
↗
November 21, 2026
Via
MarketBeat
Tickers
NKTR
Canadian National Railway Adds C$300 Million in Revenue as Port Outage Clouds Q4
↗
November 21, 2026
Via
MarketBeat
Tickers
CNI
Nasdaq Starts Charging for Financial Crime AI Agents as 850 Customers Sign On
↗
November 21, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Tickers
NDAQ
RY
TSX:RY
Exposures
Artificial Intelligence
Mesoblast Eyes Heart Failure Filing as Back Pain Trial and RYONCIL Expansion Advance
↗
November 21, 2026
Via
MarketBeat
Tickers
ASX:MSB
MESO
Deutsche Bank Sees 2026 Revenue Above €33 Billion, Reaffirms Cost Target
↗
November 21, 2026
Via
MarketBeat
Tickers
DB
JPM
RIVN
TSLA
ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
↗
November 21, 2026
Via
MarketBeat
Tickers
ZIM
SAP CFO Sees Headcount Declining as AI Boosts Productivity, Plans New Revenue Metric
↗
November 21, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Tickers
COST
MS
SAP
Exposures
Artificial Intelligence
Owens Corning's Stock Slump May Have a Silver Lining for Dividend Investors
↗
November 21, 2026
Via
MarketBeat
Tickers
GLW
OC
Cognex Sees More Margin Upside, Targets Deeper Customer Ties in 2027
↗
November 21, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Tickers
CGNX
Exposures
Artificial Intelligence
The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
↗
November 21, 2026
Via
MarketBeat
Tickers
AMZN
CHKP
JPM
MSFT
PANW
Endeavour Silver Maps $585 Million Pitarrilla Mine, With Production Possible by 2030
↗
November 21, 2026
Via
MarketBeat
Tickers
EXK
Anthropic's Record IPO Could Ease a Major Concern for Broadcom Investors
↗
November 21, 2026
Via
MarketBeat
Topics
Initial Public Offering
Tickers
ANT
AVGO
META
Exposures
Securities Market
Jazz Pharmaceuticals CEO Touts Ziihera Launch, Pipeline After Raising Revenue Guidance
↗
November 21, 2026
Via
MarketBeat
Tickers
JAZZ
MarketBeat Week in Review – 11/16 - 11/20
↗
November 21, 2026
Via
MarketBeat
Tickers
AMAT
AMZN
BRK
BRK-B
CVX
LUNR
Zillow Group Sees Ad Shift Headwind Easing as Rentals and Mortgages Fuel Growth
↗
November 21, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Tickers
RY
TSX:RY
Z
ZS
Exposures
Artificial Intelligence
Builders FirstSource Targets 18% Earnings Growth Despite Modest Housing Outlook
↗
November 21, 2026
Via
MarketBeat
Topics
Supply Chain
Tickers
BLDR
Exposures
Supply Chain
NeoGenomics Touts 29% Sequencing Growth, Plans Sales Push for Cancer Tests
↗
November 21, 2026
Via
MarketBeat
Tickers
NEO
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >